Literature DB >> 7636508

Distribution of varicella-zoster virus gpI and gpII and corresponding genome sequences in the skin.

A F Nikkels1, P Delvenne, S Debrus, C Sadzot-Delvaux, J Piette, B Rentier, G E Piérard.   

Abstract

In the course of varicella-zoster virus (VZV) infection, some viral capsid antigens are found in the epidermis and dermis. The aim of this study was to investigate the localisation of two major VZV glycoproteins (gpI and gpII) and of their respective genes in the skin. The distribution of VZV gpI and II in 27 formalin fixed paraffin embedded skin biopsies from herpes zoster eruptions were compared by immunohistochemistry. Double immunostaining was carried our to identify infected cells. The presence of viral nucleic acids coding for gpI and gpII was examined by in situ hybridisation. The distribution of gpI and gpII and their corresponding genome sequences was similar in the epidermis. gpI and gpII were also detected in dermal FXIIIa positive dendrocytes, in Mac 387 and CD68 positive macrophages, and in perineural and endothelial cells. However, the corresponding viral nucleic acids were rarely and barely detected in these cells of the dermis. It is concluded that VZV infection of epithelial cells follows a different course than in dermal cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636508     DOI: 10.1002/jmv.1890460202

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Varicella-zoster virus proteins in skin lesions: implications for a novel role of ORF29p in chickenpox.

Authors:  P W Annunziato; O Lungu; C Panagiotidis; J H Zhang; D N Silvers; A A Gershon; S J Silverstein
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Hair follicle involvement in herpes zoster: pathway of viral spread from ganglia to skin.

Authors:  R Muraki; T Iwasaki; T Sata; Y Sato; T Kurata
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

3.  Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections.

Authors:  A F Nikkels; P Delvenne; C Sadzot-Delvaux; S Debrus; J Piette; B Rentier; G Lipcsei; P Quatresooz; G E Piérard
Journal:  J Clin Pathol       Date:  1996-03       Impact factor: 3.411

4.  Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection.

Authors:  Jennifer H Huch; Anthony L Cunningham; Ann M Arvin; Najla Nasr; Saskia J A M Santegoets; Eric Slobedman; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

Review 5.  Recognition and treatment of shingles.

Authors:  A F Nikkels; G E Piérard
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

6.  Viral load and antibody boosting following herpes zoster diagnosis.

Authors:  Charlotte Warren-Gash; Harriet Forbes; Peter Maple; Mark Quinlivan; Judith Breuer
Journal:  J Clin Virol       Date:  2018-03-21       Impact factor: 3.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.